Ozempic for All?
The Daily
11/14/25
•22m
About
Comments
Featured In
Drugs like Ozempic and Zepbound have revolutionized weight loss. And starting next year, the drugs are going to become more affordable for Americans because of a deal struck with pharmaceutical companies by the Trump administration.
Eshe Nelson, who covers economics and business news, explains how the change has its origins in a huge business blunder from the creator of Ozempic, Novo Nordisk.
Guest: Eshe Nelson, a reporter for The New York Times based in London, where she covers economics and business news.
Background reading:
- How Ozempic’s maker lost its shine after creating a wonder drug.
- What Trump’s new drug pricing deal means for people with obesity.
Photo: Sergei Gapon/Agence France-Presse — Getty Images
For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.
Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.
Previous Episode
‘He Knew’: What Epstein Said About Trump in New Emails
November 13, 2025
•28m
Thousands of pages of newly released emails between Jeffrey Epstein and his associates have put the convicted sex offender’s relationship with President Trump back in the spotlight.
David Enrich and Michael Gold, who have been covering the story, explain what the new documents tell us and discuss whether they could prompt the release of the rest of the Epstein files.
Guest:
- David Enrich, a deputy investigations editor for The New York Times.
- Michael Gold, a congressional correspondent for The New York Times.
Background reading:
- Mr. Trump said the Democrats were bringing up the Epstein “hoax” to deflect from the government shutdown.
- House Republicans asserted that the emails revealed little information.
Photo: Doug Mills/The New York Times
For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.
Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.
Next Episode
The longtime editor and chronicler of the elite says she’s liberated and is letting it rip.
Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.
If you like this episode you’ll love
Promoted